Skip to main content

Table 3 Serum levels of lipophilic POPs (μg/kg lipid) in cases and controls in the two recruitment periods

From: Serum levels of environmental pollutants is a risk factor for breast cancer in Inuit: a case control study

Parameters

2000–2003

2011–2014

p-value a

p-value b

p-value c

 

Median serum levels

Median serum levels

all

cases

controls

 

All

Cases

Controls

All

Cases

Controls

   

∑PCB

1995.18

2048.80

1985.94

798.50

1014.90

577.40

<0.001

0.266

<0.001

∑PCB Grp1

173.75

172.07

173.75

76.00

93.35

53.50

<0.001

0.280

<0.001

∑PCB Grp2

755.42

696.47

767.50

220.80

290.65

173.10

<0.001

0.097

<0.001

∑PCB Grp3

1062.77

1106.39

1062.68

515.00

628.50

354.00

0.002

0.400

0.001

∑DL-PCB

173.86

149.32

182.90

60.00

70.05

49.90

<0.001

0.044

<0.001

 PCB99

78.65

70.28

81.36

31.00

38.50

23.00

<0.001

0.019

<0.001

 PCB101

7.27

5.44

9.16

3.00

3.00

3.00

<0.001

<0.001

0.012

 PCB105

19.17

16.59

22.29

5.60

7.95

5.00

<0.001

0.013

<0.001

 PCB118

99.76

99.61

99.76

34.00

48.50

32.00

<0.001

0.019

<0.001

 PCB138

378.43

357.47

385.24

110.00

165.00

79.00

<0.001

0.041

<0.001

 PCB153

585.14

636.81

583.66

270.00

355.00

200.00

0.002

0.399

0.001

 PCB156

50.00

46.13

56.63

15.00

22.50

14.00

<0.001

0.256

<0.001

 PCB170

120.00

113.62

128.75

51.00

65.50

36.00

0.005

0.676

0.001

 PCB180

353.61

349.44

353.61

170.00

195.00

120.00

0.007

0.591

0.002

 PCB183

36.94

39.83

36.72

13.00

18.50

12.00

<0.001

0.061

<0.001

 PCB187

162.05

166.19

161.95

73.00

88.00

51.00

<0.001

0.061

<0.001

∑OCP

2303.45

2531.58

2127.71

1013.00

1539.50

847.00

<0.001

0.062

<0.001

 Cis-Nonachlor

79.29

94.30

77.84

40.00

46.50

29.00

<0.001

0.165

0.001

 Trans-Nonachlor

405.42

509.67

343.07

200.00

270.00

150.00

0.011

0.606

0.004

 HCB

257.01

265.04

257.01

110.00

130.00

85.00

<0.001

0.008

<0.001

 Mirex

37.50

33.52

40.82

19.00

21.00

13.00

0.009

0.926

0.010

 Oxychlordane

235.94

301.72

213.64

110.00

115.00

82.00

0.005

0.429

0.003

 p,p’DDE

1129.46

1288.21

1039.19

550.00

680.00

420.00

<0.001

0.018

<0.001

 p,p’DDT

29.51

31.54

25.00

9.50

10.00

8.00

<0.001

<0.001

<0.001

 βHCH

40.63

42.26

38.96

15.00

17.50

12.00

<0.001

0.004

<0.001

  1. The differences between the two recruitment periods were tested with independent samples t-test. aThe p-value form independent samples t-test on ln-transformed variables between all the participants; bThe p-value from independent samples t-test on ln-transformed variables between the cases; cThe p-value from independent samples t-test on ln-transformed variables between the controls; Bold text: significant finding; ∑PCB: PCB 99, 101, 105, 118, 128, 138, 153, 156, 170, 180, 183, 187; ∑PCB group 1 (estrogenic PCBs): PCB 101, 187; ∑PCB group 2 (anti-estrogenic and dioxin-like PCBs): PCB 105, 118, 128, 138, 156, 170; ∑PCB group 3 (CYP1A1 and CYP2B inducing PCBs): PCB 99, 153, 180, 183; ∑DL-PCBs (dioxin-like PCBs): PCB 105, 118, 156; ∑OCP: p,p′-DDT, p,p′-DDE, mirex, β-HCH, HCB, cis- and trans-nonachlor, and oxychlordane. The serum concentration of the lipophilic POPs was measured in μg/kg lipid